Evidence map›Paper›PMID 36593448›Full record

ArticleBMC geriatrics2023

Association between Clinical Frailty Scale (CFS) and clinical presentation and outcomes in older inpatients with COVID-19.

Ana Martí-Pastor, Oscar Moreno-Perez, Esther Lobato-Martínez, Fatima Valero-Sempere, Antonio Amo-Lozano, María-Ángeles Martínez-García, Esperanza Merino, Rosario Sanchez-Martinez, Jose-Manuel Ramos-Rincon

Abstract read
In one paragraph

Article in BMC geriatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Diagnosis of frailty and implications on surgical process in the elderly: A narrative review.European journal of anaesthesiology and intensive care · 2023
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Martí-PastorInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain.ORCID 0000-0001-6369-5821
Oscar Moreno-PerezEndocrinology and Nutrition Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.ORCID 0000-0002-8670-6404
Esther Lobato-MartínezInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain.ORCID 0000-0002-1138-2388
Fatima Valero-SempereInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain.ORCID 0000-0002-0921-1854
Antonio Amo-LozanoInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain.ORCID 0000-0002-7269-0747
María-Ángeles Martínez-GarcíaPulmonogy Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.ORCID 0000-0002-5475-089X
Esperanza MerinoInfectious Diseases Unit, Alicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis General University Hospital, Alicante, Spain.ORCID 0000-0003-3854-4874
Rosario Sanchez-MartinezInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain.ORCID 0000-0003-3825-0198
Jose-Manuel Ramos-RinconInternal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Calle Pintor Baeza, 12. CP 03010, Alicante, Spain. jose.ramosr@umh.es.ORCID 0000-0001-7922-5664

Funding

Alicante Institute for Health and Biomedical Research (ISABIAL) 2021-0390
6 · The paper itself

Abstract

backgroundFrailty is a physiological condition characterized by a decreased reserve to stressors. In patients with COVID-19, frailty is a risk factor for in-hospital mortality. The aim of this study was to assess the relationship between clinical presentation, analytical and radiological parameters at admission, and clinical outcomes according to frailty, as defined by the Clinical Frailty Scale (CFS), in old people hospitalized with COVID-19. MATERIALS AND

methodsThis retrospective cohort study included people aged 65 years and older and admitted with community-acquired COVID-19 from 3 March 2020 to 31 April 2021. Patients were categorized using the CFS. Primary outcomes were symptoms of COVID-19 prior to admission, mortality, readmission, admission in intensive care unit (ICU), and need for invasive mechanical ventilation. Analysis of clinical symptoms, clinical outcomes, and CFS was performed using multivariable logistic regression, and results were expressed as odds ratios (ORs) and 95% confidence intervals (CIs).

resultsOf the 785 included patients, 326 (41.5%, 95% CI 38.1%-45.0%) were defined as frail (CFS ≥ 5 points): 208 (26.5%, 95% CI 23.5%-29.7%) presented mild-moderate frailty (CFS 5-6 points) and 118 (15.0%, 95% CI 12.7%-17.7%), severe frailty (7-9 points). After adjusting for epidemiological variables (age, gender, residence in a nursing home, and Charlson comorbidity index), frail patients were significantly less likely to present dry cough (OR 0.58, 95% CI 0.40-0.83), myalgia-arthralgia (OR 0.46, 95% CI 0.29-0.75), and anosmia-dysgeusia (OR 0.46, 95% CI 0.23-0.94). Confusion was more common in severely frail patients (OR 3.14; 95% CI 1.64-5.97). After adjusting for epidemiological variables, the risk of in-hospital mortality was higher in frail patients (OR 2.79, 95% CI 1.79-4.25), including both those with mild-moderate frailty (OR 1.98, 95% CI 1.23-3.19) and severe frailty (OR 5.44, 95% CI 3.14-9.42). Readmission was higher in frail patients (OR 2.11, 95% CI 1.07-4.16), but only in mild-moderate frailty (OR 2.35, 95% CI 1.17-4.75)..

conclusionFrail patients presented atypical symptoms (less dry cough, myalgia-arthralgia, and anosmia-dysgeusia, and more confusion). Frailty was an independent predictor for death, regardless of severity, and mild-moderate frailty was associated with readmission.

Indexed as

COVID-19FrailtyAgedAnosmiaCoughDysgeusiaFrail ElderlyGeriatric AssessmentHumansInpatientsLength of StayMyalgiaRetrospective StudiesAnosmiaArthralgiasCohort studyConfusionCoughCOVID-19DysgeusiaFrail elderlyMortalityMyalgiasPatient readmissionSpainSymptom assessment

Identifiers

PMID36593448
PMCPMC9806809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.